Martel-Lafay, I.; Monnet, I.; Lardy-Cleaud, A.; Danhier, S.; Salem, N.; Gallocher, O.; Fournel, P.; Chouaid, C.; Bylicki, O.; the GFPC 01-14 Investigators.
Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14). Curr. Oncol. 2021, 28, 3804-3811.
https://doi.org/10.3390/curroncol28050324
AMA Style
Martel-Lafay I, Monnet I, Lardy-Cleaud A, Danhier S, Salem N, Gallocher O, Fournel P, Chouaid C, Bylicki O, the GFPC 01-14 Investigators.
Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14). Current Oncology. 2021; 28(5):3804-3811.
https://doi.org/10.3390/curroncol28050324
Chicago/Turabian Style
Martel-Lafay, Isabelle, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid, Olivier Bylicki, and the GFPC 01-14 Investigators.
2021. "Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)" Current Oncology 28, no. 5: 3804-3811.
https://doi.org/10.3390/curroncol28050324
APA Style
Martel-Lafay, I., Monnet, I., Lardy-Cleaud, A., Danhier, S., Salem, N., Gallocher, O., Fournel, P., Chouaid, C., Bylicki, O., & the GFPC 01-14 Investigators.
(2021). Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14). Current Oncology, 28(5), 3804-3811.
https://doi.org/10.3390/curroncol28050324
